Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132165) titled 'Application and Demonstration of AI-Assisted Breast Cancer Screening Technology in Resource-limited Settings' on Sept. 10.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Cancer Hospital Chinese Academy of Medical Sciences
Condition:
breast cancer
Intervention:
Gold Standard:Pathological examination: 1. Diagnosis can be completed in our hospital, or pathology results can be tracked
2. Pathology slides can be borrowed for expert quality control.
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2024-10-14
Target Sample Size: Target condition:...